Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-18

Clinical Trial Update: Adjunctive Quetiapine in the Treatment of Refractory Social Anxiety Disorder in Adults [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating adjunctive quetiapine for adults with refractory social anxiety disorder has completed. The document provides an update on the study st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Quetiapine (quetiapine)

Snippet

Sponsor: Cambridge Health Alliance | Conditions: Social Anxiety Disorder | Phase 4 | Status: COMPLETED